Kevan Shokat

Startup aims to tackle “undruggable” neuro targets with tech from ...

This Endpoints News article explores the creation of Montara Therapeutics by Kevan Shokat and Nicholas Hertz after selling their first neuro startup to AbbVie.

Strategies for drugging undruggable targets in oncology: From K ...

Kevan Shokat Professor and Chair Department of Cellular and Molecular Pharmacology University of California, San Francisco Abstract.

Dr. Kevan Shokat - Kick KRAS Expert series - Facebook

Kevan Shokat is one of the primary researchers that has made KRAS is a druggable target. Tuesday April 5 at 6 pm ET Virtual/ Live We are honored to have a ...

Drugging the undruggable: Ross Cagan interviews Kevan Shokat

Drugging the undruggable: Ross Cagan interviews Kevan Shokat-article.

A Chemical Genetic System for the Analysis of Kinases Regulating T ...

Kevan Shokat;. Kevan Shokat. ‡Department of Cellular and Molecular Pharmacology, University of California San Francisco, CA 94143. Search for other works by ...

Kevan Shokat Inventions, Patents and Patent Applications

In an aspect is provided a p53 protein covalently bonded to a compound described herein. In an aspect is provided a pharmaceutical composition including a ...

Initial launches with $75M and a new idea for targeting problematic ...

The company was co-founded by Jamie Cate, husband of CRISPR pioneer Jennifer Doudna, and Kevan Shokat, a chemical biologist whose previous ...

Chemistry Turner Lecture: Kevan Shokat - Rice University Events

Overcoming the Undruggable Nature of The Most Common Human Oncogene K-Ras.

Engineering Orthogonal Protein Kinase and Nucleotides - Grantome

Engineering Orthogonal Protein Kinase and Nucleotides Shokat, Kevan M. University of California San Francisco, San Francisco, CA, United States.

Kevan Shokat on X

Kevan Shokat · @kevansf. Congratulations. @DoctorBou. so excited to hear about the first discoveries from the lab! Can't wait to collaborate on ...

Kevan Shokat is interviewed by David Zierler for the ... - YouTube

Kevan Shokat, Professor of Cellular and Molecular Pharmacology, University of California, San Francisco, and Professor of Chemistry, ...

Novel chemical genetic approaches to the discovery of signal ...

Novel chemical genetic approaches to the discovery of signal transduction inhibitors. Author links open overlay panel. Kevan Shokat a , Mark Velleca b. Show ...

Kevan Shokat, PhD - Biomedical Sciences Graduate Program

The Shokat lab uses chemical genetics to study and target signaling proteins, with the aim of finding new ways to treat human diseases.

Kevan Shokat Ph.D. To Be Awarded The First SWCRF Breakthrough ...

The Samuel Waxman Cancer Research Foundation (SWCRF) will present its first SWCRF Breakthrough Science Award to Dr. Kevan Shokat.

Kevan Shokat (UCSF) - Wheland Lecture | Calendar of Events

Overcoming the Undruggable Nature of the Most Common Human Oncogene K-Ras Somatic mutations in the small GTPase K-Ras are the most common activ...

Dr. Kevan Shokat, Author at Curetalks

Kevan Shokat | CureTalks. Dr. Kevan Shokat is a professor in the Department of Cellular and Molecular Pharmacology at UCSF and the ...

Sjöberg Laureate brings new hope to people with lung cancer

Kevan M. Shokat was born in Boulder City, Nevada, USA, in 1964. He was awarded a Ph.D. in organic chemistry by the University of California ...

Direct Modulators of K-Ras–Membrane Interactions - ACS Publications

Madison, Madison, WI, 53706, USA. *. [email protected]. ;. *[email protected].

Drugging the undruggable: Ross Cagan interviews Kevan Shokat

Ross Cagan interviews Kevan Shokat. In collection: The RAS Pathway. Ross Cagan ORCID logo 0000-0001-5297-450X , Ross Cagan * *E-mail: [email protected]

Dr. Kevan Shokat '86 Receives Vollum Award for Cancer Research

Last Thursday, February 9, Kevan M. Shokat, Ph.D., Reed Class of 1986, received the Vollum Award for Distinguished Accomplishment in Science ...

Kevan Shokat

Kevan Michael Shokat is an American chemical biologist. He is a Professor and chair in the Department of Cellular and Molecular Pharmacology at University of California, San Francisco, a professor in the Department of Chemistry at University of California, Berkeley, and an Investigator with the Howard Hughes Medical Institute.